Cognito achieves enrolment target in trial of Spectris system for Alzheimer's
Summary by Medical Device Network
1 Articles
1 Articles
All
Left
Center
Right
Cognito achieves enrolment target in trial of Spectris system for Alzheimer's
Cognito Therapeutics has reached its enrolment goal for the HOPE Study investigating the Spectris AD system for Alzheimer's disease (AD).The post Cognito achieves enrolment target in trial of Spectris system for Alzheimer’s appeared first on Medical Device Network.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium